What does APOTHEEK OPGRIMBIE do?

APOTHEEK OPGRIMBIE is a pharmacy in Maasmechelen. Private Limited, started on 26 June 1984, 1 establishment.

What is the address of APOTHEEK OPGRIMBIE?

The registered office of APOTHEEK OPGRIMBIE is located at Heirstraat(V) 515 box B, 3630 Maasmechelen.

Is APOTHEEK OPGRIMBIE still active?

Yes. According to the CBE (30 October 2026) APOTHEEK OPGRIMBIE is active, legal situation “Normale toestand”, started on 26 June 1984.

Is APOTHEEK OPGRIMBIE registered on Peppol?

Yes, APOTHEEK OPGRIMBIE is registered on the Peppol network with ID 0208:0426076359.

What is the enterprise number of APOTHEEK OPGRIMBIE?

The enterprise number of APOTHEEK OPGRIMBIE is BE0426076359.

When was APOTHEEK OPGRIMBIE founded?

APOTHEEK OPGRIMBIE was founded on 26 June 1984.

Who are the directors of APOTHEEK OPGRIMBIE?

According to the 2025 annual accounts, the directors of APOTHEEK OPGRIMBIE are: Varmaca BV.

Is APOTHEEK OPGRIMBIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 June 1984; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK OPGRIMBIE make in 2025?

APOTHEEK OPGRIMBIE posted a profit after taxes of € 193,063 in financial year 2025.

What is the revenue of APOTHEEK OPGRIMBIE?

As a small company, APOTHEEK OPGRIMBIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 417,699.

How much does an employee at APOTHEEK OPGRIMBIE earn?

The average wage cost per full-time employee at APOTHEEK OPGRIMBIE was € 68,100 in 2025: staff costs of € 115,701 for 1.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK OPGRIMBIE have?

According to the 2025 annual accounts, APOTHEEK OPGRIMBIE has 1.7 full-time equivalents (FTE).

APOTHEEK OPGRIMBIE (Private Limited) - Maasmechelen

Dossier APOTHEEK OPGRIMBIE, printed on 30 October 2026 from databakkes.be/en/0426076359/apotheek-opgrimbie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK OPGRIMBIE from Maasmechelen, company number BE0426076359, closed financial year 2025 with a result of € 193,063 after tax. For that financial year APOTHEEK OPGRIMBIE recorded a gross margin of € 417,699 and equity of € 254,256. Compared with financial year 2024, the result moved from € 166,050 to € 193,063. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 254,256

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 193,063

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 385,042

▲ 203% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 190,500 paid out

99 % of the profit went to the shareholders, mostly to Varmaca (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.7

▲ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 115,701

▲ 90% vs 2024

€ 68,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,550

▲ 168% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 765,336

▲ 93% vs 2024

€ 87,658 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 212,752

▲ € 162,054 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 23,097

▲ 17% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 313,458 Gross margin 2022: € 313,458 First fiscal year in the series	€ 297,856 Gross margin 2023: € 297,856 ▼ 5% vs 2022 (€ 313,458) Unfavourable step	€ 307,249 Gross margin 2024: € 307,249 ▲ 3% vs 2023 (€ 297,856) Favourable step	€ 417,699 Gross margin 2025: € 417,699 ▲ 36% vs 2024 (€ 307,249) Favourable step	▲ 36%
Profit after taxes	€ 240,448 Profit after taxes 2022: € 240,448 First fiscal year in the series	€ 203,218 Profit after taxes 2023: € 203,218 ▼ 15% vs 2022 (€ 240,448) Unfavourable step	€ 166,050 Profit after taxes 2024: € 166,050 ▼ 18% vs 2023 (€ 203,218) Unfavourable step	€ 193,063 Profit after taxes 2025: € 193,063 ▲ 16% vs 2024 (€ 166,050) Favourable step	▲ 16%
Equity	€ 243,902 Equity 2022: € 243,902 First fiscal year in the series	€ 254,120 Equity 2023: € 254,120 ▲ 4% vs 2022 (€ 243,902) Favourable step	€ 254,169 Equity 2024: € 254,169 Unchanged (€ 254,120) Favourable step	€ 254,256 Equity 2025: € 254,256 Unchanged (€ 254,169) Favourable step
Total debts	€ 912,837 Total debts 2022: € 912,837 First fiscal year in the series	€ 955,458 Total debts 2023: € 955,458 ▲ 5% vs 2022 (€ 912,837) Unfavourable step	€ 631,580 Total debts 2024: € 631,580 ▼ 34% vs 2023 (€ 955,458) Favourable step	€ 1,196,639 Total debts 2025: € 1,196,639 ▲ 89% vs 2024 (€ 631,580) Unfavourable step	▲ 89%
Cash	€ 228,513 Cash 2022: € 228,513 First fiscal year in the series	€ 321,994 Cash 2023: € 321,994 ▲ 41% vs 2022 (€ 228,513) Favourable step	€ 126,932 Cash 2024: € 126,932 ▼ 61% vs 2023 (€ 321,994) Unfavourable step	€ 385,042 Cash 2025: € 385,042 ▲ 203% vs 2024 (€ 126,932) Favourable step	▲ 203%
Land & buildings	€ 377,074 Land & buildings 2022: € 377,074 First fiscal year in the series	€ 356,449 Land & buildings 2023: € 356,449 ▼ 5% vs 2022 (€ 377,074) Unchanged	€ 336,982 Land & buildings 2024: € 336,982 ▼ 5% vs 2023 (€ 356,449) Unchanged	€ 318,601 Land & buildings 2025: € 318,601 ▼ 5% vs 2024 (€ 336,982) Unchanged	▼ 5%
Retained profit	€ 235,225 Retained profit 2022: € 235,225 First fiscal year in the series	€ 245,443 Retained profit 2023: € 245,443 ▲ 4% vs 2022 (€ 235,225) Favourable step	€ 245,493 Retained profit 2024: € 245,493 Unchanged (€ 245,443) Favourable step	€ 245,580 Retained profit 2025: € 245,580 Unchanged (€ 245,493) Favourable step
Dividend	€ 240,000 Dividend 2022: € 240,000 First fiscal year in the series	€ 193,000 Dividend 2023: € 193,000 ▼ 20% vs 2022 (€ 240,000) Unchanged	€ 166,000 Dividend 2024: € 166,000 ▼ 14% vs 2023 (€ 193,000) Unchanged	€ 190,500 Dividend 2025: € 190,500 ▲ 15% vs 2024 (€ 166,000) Unchanged	▲ 15%
Bank debt	€ 378,310 Bank debt 2022: € 378,310 First fiscal year in the series	€ 442,136 Bank debt 2023: € 442,136 ▲ 17% vs 2022 (€ 378,310) Unfavourable step	€ 397,301 Bank debt 2024: € 397,301 ▼ 10% vs 2023 (€ 442,136) Favourable step	€ 765,336 Bank debt 2025: € 765,336 ▲ 93% vs 2024 (€ 397,301) Unfavourable step	▲ 93%
Balance sheet total	€ 1,156,739 Balance sheet total 2022: € 1,156,739 First fiscal year in the series	€ 1,209,578 Balance sheet total 2023: € 1,209,578 ▲ 5% vs 2022 (€ 1,156,739) Unchanged	€ 885,750 Balance sheet total 2024: € 885,750 ▼ 27% vs 2023 (€ 1,209,578) Unchanged	€ 1,450,895 Balance sheet total 2025: € 1,450,895 ▲ 64% vs 2024 (€ 885,750) Unchanged	▲ 64%
Employees (FTE)	0.7 Employees (FTE) 2022: 0.7 First fiscal year in the series	0.9 Employees (FTE) 2023: 0.9 ▲ 0.2 vs 2022 (0.7) Unchanged	1 Employees (FTE) 2024: 1 ▲ 0.1 vs 2023 (0.9) Unchanged	1.7 Employees (FTE) 2025: 1.7 ▲ 0.7 vs 2024 (1) Unchanged	▲ 0.7

Key figures of APOTHEEK OPGRIMBIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK OPGRIMBIE?

What happened at APOTHEEK OPGRIMBIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 193,063 (▲ 16% vs 2024). Source: NBB ↗
2025 Varmaca BV became a director. NBB
Jul 1, 1984 New establishment in Maasmechelen. KBO
Jun 26, 1984 Start of the company according to the CBE. KBO

In short

From € 240,448 profit in 2022 to € 193,063 profit in 2025.

Paid € 73,286 in corporate taxes since 2022.

Best year ever: 2022, with € 240,448 profit.

On average € 245,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Varmaca 100%

MANAGEMENT THEUNISSEN 99.5%

The stake of Varmaca, MANAGEMENT THEUNISSEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK OPGRIMBIE

Behind APOTHEEK OPGRIMBIE is Varmaca BV. The shares are held by Varmaca (100%) and MANAGEMENT THEUNISSEN (99.5%).

Directors

According to the 2025 annual accounts

Varmaca BV

Director · represented by Maarten Vanthoor

Also active at: APOTHEEK VANTHOOR - VANKEVELAER

since 2025

Shareholders

Varmaca

100%

MANAGEMENT THEUNISSEN

99.5%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heirstraat(V) 515 box B

3630 Maasmechelen

2.024.871.436

Heirstraat(E) 515 box B

3630 Maasmechelen

Active since 1 July 1984

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.076.359

VAT number

BE 0426.076.359

Registered office

Heirstraat(V) 515 bus B, 3630 Maasmechelen

Names & denominations

APOTHEEK OPGRIMBIE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 June 1984

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK OPGRIMBIE

Financials

What happened to APOTHEEK OPGRIMBIE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions